 |
PDBsum entry 3sie
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
3sie
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/hydrolase inhibitor
|
 |
|
Title:
|
 |
Crystal structure of the pde5a1 catalytic domain in complex with novel inhibitors
|
|
Structure:
|
 |
Cgmp-specific 3',5'-cyclic phosphodiesterase. Chain: a, b. Fragment: unp residues 535-860. Synonym: pde5a1, cgmp-binding cgmp-specific phosphodiesterase, cgb- pde. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Organism_taxid: 9606. Gene: pde5, pde5a. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Resolution:
|
 |
|
1.93Å
|
R-factor:
|
0.193
|
R-free:
|
0.235
|
|
|
Authors:
|
 |
T.T.Chen,T.Chen,Y.C.Xu
|
|
Key ref:
|
 |
Z.Xu
et al.
(2011).
Utilization of halogen bond in lead optimization: a case study of rational design of potent phosphodiesterase type 5 (PDE5) inhibitors.
J Med Chem,
54,
5607-5611.
PubMed id:
|
 |
|
Date:
|
 |
|
17-Jun-11
|
Release date:
|
24-Aug-11
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
O76074
(PDE5A_HUMAN) -
cGMP-specific 3',5'-cyclic phosphodiesterase from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
875 a.a.
297 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.1.4.35
- 3',5'-cyclic-GMP phosphodiesterase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
3',5'-cyclic GMP + H2O = GMP + H+
|
 |
 |
 |
 |
 |
3',5'-cyclic GMP
|
+
|
H2O
|
=
|
GMP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
J Med Chem
54:5607-5611
(2011)
|
|
PubMed id:
|
|
|
|
|
| |
|
Utilization of halogen bond in lead optimization: a case study of rational design of potent phosphodiesterase type 5 (PDE5) inhibitors.
|
|
Z.Xu,
Z.Liu,
T.Chen,
T.Chen,
Z.Wang,
G.Tian,
J.Shi,
X.Wang,
Y.Lu,
X.Yan,
G.Wang,
H.Jiang,
K.Chen,
S.Wang,
Y.Xu,
J.Shen,
W.Zhu.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |